New York, Nov, 22, 2017: Axiom Market Research & Consulting added a new report on North American Clinical Chemistry Analzyers Market, by Type, Test, End User and Country Forecast upto 2024. The North American clinical chemistry analyzers market is estimated to grow at a CAGR of 4.1% during the forecast period 2019 to 2024 to reach at USD 60.5 billion by 2024. The growth of the market is fueled by factors such as, increasing healthcare expenditure, growing ageing population & prevalence of lifestyle diseases, increasing medical insurance in the United States etc. in the region.
Download sample report: http://axiommrc.com/request-for-sample?report=1374
The report covers various types of fully automatic and semi-automatic devices. The major types of analyzers considered in this report are devices which include semi-automated and automated, further divided into entry level, medium throughput analyzers, high throughput analyzers, and high throughput modular analyzers along with reagents which include metabolites, enzymes, electrolytes and others which include proteins, lipoprotein and others. By test type, the clinical chemistry market is segmented by basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel and specialty chemicals. The North American clinical chemistry analyzers market was studied for United States, Canada and Mexico. The North American countries such as, the United States and Canada are most mature and diversified markets. The United States alone contributed major share of revenue in 2017 to North American clinical chemistry analyzers market.
Browse report details: http://axiommrc.com/product/1374-na-clinical-chemistry-market-report
The reagents and consumables segment dominated the North American clinical chemistry analyzers market. There are changing trends in manufacturing and usage of clinical chemistry devices. The devices are made to suit the reagents that utilize the latest formulations and technologies for accurate quantitative determination of enzymes, electrolytes, and substrates. Fully automated devices are highly demanded which need minimum human input and thus can be flawless in terms of diagnostics. Along with this, there is an increasing trend of developing point of care (POC) and combinational testing for patient’s ease and convenience.
Hospitals end user segment still dominates the global clinical chemistry analyzers market globally. There are around 9,000 laboratories situated in 6,000 hospitals in the U.S. Hospitals have significant capital and skilled physician practices to cater their patient inflow with the facilities and latest technologies. To be at the price competition of clinical chemistry testing to private laboratories, hospitals are offering services as low as the private labs price. Another factor driving the hospital end user segment is advanced clinical chemistry analyzers which are a combination clinical chemistry and immunoassays devices. Hospitals have ample funds and high test volume to install latest clinical chemistry analyzers in their labs.
The key companies that lead the North American clinical chemistry analyzers market are Abbott Laboratories, Becker Coulter (Acquired by Danaher Corporation), Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche, Siemens AG, Thermo Fisher Scientific Inc., Horiba Ltd, Elitech Group, Randox Laboratories Ltd and Mindray Medical International Limited.
Other Reports From Axiom MRC
In Vitro Diagnostics Market Research Report, By Type, Technique, Therapeutic Application, End Users And Geography – Global Market Share, Trend Analysis And Forecast Up To 2024
Point Of Care (POC) Diagnostics Market Research Report, By Type, Application & End User – Global Market Share, Trend Analysis And Forecast Up To 2023
About Axiom MRC:
Axiom Market Research & Consulting was founded with a sole intention of providing growing companies with key actionable data for helping them take informed business decisions pertaining to their investments, marketing strategies, market competition, new product launches and etc.
Axiom MRC believes that for being able to take good strategic decisions or for business planning, companies need to understand and interpret the current market scenarios correctly. Axiom MRC follows a scientifically developed research methodology where the end to end value chain of the industry vertical is studied. Axiom MRC’s research methodology helps to extract, analyze and compare markets along with peer markets, main or parent market, application and end user industries, competitive landscape and qualitative figures to arrive at market numbers.Axiom MRC also validates the market findings with key industry professionals and its client network and takes their opinion into consideration. The key findings are presented with smart infographics for better and easy understanding.
Backed by a team of experienced senior analyst, who have worked with leading research firms and delivered number of market research projects globally, Axiom MRC is able to cater to all market research and business consulting requirements.
Axiom MRC offers business consulting, syndicated and custom market research reports across various industry verticals such as life science, chemicals & materials, food & beverages, packaging, agriculture, power & energy.
Company Name: Axiom MRC
Contact Person: Ganesh Sai
Phone: +1 (845) 875-9786
Address:616 Corporate Way, Suite 2-4268
City: Valley Cottage
Country: United States